Hyperion Defi, Inc. (HYPD): Total Liabilities
$10.70M
As of 2025-12-31
$11.20M
As of 2026-06-30
-8.1%
3-year compound annual growth
-10.5%
5-year compound annual growth
| Period ended | Total Liabilities | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $10.70M | -36.1% | 2026-03-30, Balance as of period end |
| 2024-12-31 | $16.76M | -15.3% | 2026-03-30, Balance as of period end |
| 2023-12-31 | $19.78M | +43.3% | 2025-04-15, Balance as of period end |
| 2022-12-31 | $13.80M | +23.3% | 2024-03-18, Balance as of period end |
| 2021-12-31 | $11.19M | -39.8% | 2023-03-31, Balance as of period end |
| 2020-12-31 | $18.60M | +529.1% | 2022-03-30, Balance as of period end |
| 2019-12-31 | $2.96M | -5.8% | 2021-03-30, Balance as of period end |
| 2018-12-31 | $3.14M | +468.3% | 2020-03-30, Balance as of period end |
| 2017-12-31 | $552.6K | n/a | 2019-03-27, Balance as of period end |
Total Liabilities at similar companies
| Company | Year ended | Total Liabilities | Change YoY |
|---|---|---|---|
| Hyperion Defi, Inc. (HYPD) | 2025-12-31 | $10.70M | -36.1% |
| Onconetix, Inc. (ONCO) | 2025-12-31 | $9.16M | -50.7% |
| Rallybio Corp (RLYB) | 2025-12-31 | $4.30M | -33.3% |
| Rafael Holdings, Inc. (RFL) | 2025-07-31 | $15.74M | +48.8% |
| Lexaria Bioscience Corp. (LEXX) | 2025-08-31 | $1.57M | +30.1% |
| Shattuck Labs, Inc. (STTK) | 2025-12-31 | $8.64M | -24.4% |
| 60 Degrees Pharmaceuticals, Inc. (SXTP) | 2025-12-31 | $1.99M | +10.1% |
| Polomar Health Services, Inc. (PMHS) | 2025-12-31 | $1.61M | +19.2% |
| Dare Bioscience, Inc. (DARE) | 2025-12-31 | $29.63M | +5.4% |
Compare HYPD, ONCO, RLYB, RFL side by side · Screen every company in Pharmaceutical Preparations ↗